You have probably seen the pictures from an Ebola outbreak. Isolation units, protective suits, and healthcare workers moving carefully between beds. Most of us assume there is a clear treatment plan behind that scene.
On June 17, 2026, the World Health Organization released its first ever comprehensive clinical management guidelines for filovirus diseases, the family of viruses that includes Ebola and Marburg.
Until this summer, no agreed international standard existed for how to care for patients with these diseases. The gap persisted even though Marburg was identified in 1967 and Ebola in 1976.
The new document sets out 16 evidence-based recommendations covering every known strain, from Zaire Ebola to Sudan virus, Bundibugyo and Marburg.
Also read: Marburg kills about half the people it infects. Two vaccines are now being tested
What early supportive care actually means
There is still no licensed vaccine or specific treatment for Marburg, Bundibugyo or Sudan virus disease. Survival therefore depends on supportive care, meaning the medical steps that keep a patient alive while the body fights the infection.
The guidelines prioritize three things. Fast rehydration, treatment for shock, and antibiotics when a bacterial infection is also present.
For rehydration, the panel recommends drinking fluids by mouth where possible. Where a drip is needed, balanced fluids such as Ringer's lactate are preferred over ordinary saline.
For patients in shock, the guidelines call for starting the blood pressure drug norepinephrine early rather than waiting. According to Global Biodefense's summary, the evidence points to lower mortality and fewer heart rhythm problems than with older options.
Also read: Inside the bat cave where scientists watched Marburg virus prepare to jump to humans
When a bacterial infection is suspected on top of the virus, broad coverage antibiotics should be started quickly. The guidelines also urge doctors to stop them again as soon as the picture is clearer, to limit antibiotic resistance.
Why the timing of the guidelines matters
The timing is not an accident. As WHO published the document, the Democratic Republic of the Congo was already battling the second largest Ebola outbreak on record, caused by the Bundibugyo strain.
Figures reported by Al Jazeera on October 13, 2026, citing the DRC Health Ministry, put the outbreak at 9,066 confirmed cases and 4,381 deaths across seven provinces in the north and east of the country. That is a case fatality ratio near 48 percent.
That is why better guidelines matter now rather than later. The more clinicians in outbreak zones who know when to start a drip, which blood pressure drug to reach for, and when to add antibiotics, the more patients may survive.
Also read: RFK Jr. launched a health movement: here is what MAHA actually stands for
A clinical trial testing a vaccine against the Bundibugyo strain is being prepared for the DRC in the coming weeks. The timeline comes from WHO Health Emergencies Programme Executive Director Chikwe Ihekweazu.
```Also read: Labs handling the world's deadliest viruses have doubled in a decade, and most are now in cities
This article is made and published by Aksel Kryhlmand, who may have used AI in the preparation.